Treatment failure in a typhoid patient infected with nalidixic acid resistant S. enterica serovar Typhi with reduced susceptibility to ciprofloxacin: A case report from Cameroon

BMC Infectious Diseases

Volumn 5, Issue , 2005, Pages

  Nkemngu, Njinkeng J ^a,b   Asonganyi, Etienne D N ^b,c   Njunda, Anna L ^d  

^a St John's Maternity and Hospital   (Cameroon)

^b St Joseph's Medical Centre   (Cameroon)

^c UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^d UNIVERSITY OF BUEA   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD CULTURE; CAMEROON; CASE REPORT; DRUG CHOICE; FEMALE; FEVER; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; SALMONELLA ENTERICA; SALMONELLA TYPHI; TREATMENT FAILURE; TYPHOID FEVER; DRUG EFFECT; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ADULT; ANTI-BACTERIAL AGENTS; CAMEROON; CEFTRIAXONE; CIPROFLOXACIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; MICROBIAL SENSITIVITY TESTS; NALIDIXIC ACID; SALMONELLA TYPHI; TREATMENT FAILURE; TYPHOID FEVER;

EID: 27244439643     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-5-49     Document Type: Article

References (12)

1. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial disk susceptibility test. National Committee for Clinical Laboratory Standards, Wayne, Pa 1999. Ninth information supplement M100-S9
2. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility test for bacterial that grow aerobically. Approved standard M7-A5. National Committee forclinical Laboratory Standards, Wayne, Pa 2000.
3. Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ: Typhoid fever. N Engl J Med 2002, 347:1770-1782.
4. Butt Tariq, Ahmad Rifat Nadeem, Mahmood Abid, Zaidi Sabeen: Ciprofloxacin Treatment Failure in Typhoid Fever Case, Pakistan. Emerging Infectious Diseases 2003, 9:1621-1622.
5. Kariuki S, Revathi G, Muyodi J, Mwituria J, Munyalo A, Mirza S, Hart CA: Characterization of multidrug-resistant typhoid outbreaks in Kenya. Clin Microbiol 2004, 42:1477-1482.
6. Hakanen A, Kotilainen P, Jalava J, Siitonen A: Detection of decreased fluoroquinolone susceptibility and validation of nalidixic acid screening test. J Clin Microbiol 1999, 37:3572-3577.
7. Threlfall EJ, Ward LR: Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype Typhi, United Kingdom. Emerg Infect Dis 2001, 7:448-450.
8. Mehta G, Randhawa VS, Mohapatra NP: Intermediate susceptibility to ciprofloxacin in Salmonella enterica serovar Typhi strains in India. Eur J Clin Microbiol Infect Dis 2001, 20:760-761.
9. Wain J, Hoa NT, Chinh NT, et al.: Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment. Clin Infect Dis 1997, 25:1404-10.
10. Kariuki S, Gilks C, Revathi G, Hart CA: Genotypic Analysis of Multidrug-Resistant Salmonella enterica Serovar Typhi, Kenya. Emerg Infect Dis 2000, 6:649-651.
11. Hakanen A, Kotilainen P, Huovinen P, Helenius H, Siitonen A: Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia. Emerg Infect Dis 2001, 7:996-1003.
12. Chinh NT, Parry CM, LY NT, et al.: A Randomized Controlled Comparison of Azithromycin and Ofloxacin for Treatment of Multidrug-Resistant or Nalidixic Acid-Resistant Enteric Fever. Antimicrobial Agents Chemother 2000, 44:1855-1859.